Michael H. Davidson, Chief Executive Officer at NewAmsterdam Pharma Co N.V. (NAMS), bought 5,000 shares at $16.27 ($81K) on 2024-08-20, disclosed to the SEC on 2024-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| NAMS | SELL | 2026-02-26 | $10.6M | — | Filing → |
| NAMS | BUY | 2024-06-24 | $173K | — | Filing → |
| CLBS | BUY | 2020-09-10 | $100K | — | Filing → |